Please login to the form below

Not currently logged in
Email:
Password:

Norway

This page shows the latest Norway news and features for those working in and with pharma, biotech and healthcare.

CEPI says $2bn is needed for COVID-19 vaccine development

CEPI says $2bn is needed for COVID-19 vaccine development

The German government’s Federal Ministry of Education and Research has already provided £157m to support CEPI’s development of a COVID-19 vaccine, joining the governments of Norway and the

Latest news

More from news
Approximately 1 fully matching, plus 125 partially matching documents found.

Latest Intelligence

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    The Coalition for Epidemic Preparedness Innovations (CEPI), an Oslo, Norway-based nonprofit, is helping to coordinate the development of a COVID-19 vaccine and is leading the efforts to finance the

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    Notably the biosimilar Renflexis (infliximab-abda) achieved a 70-80% price reduction to its reference product in both Norway and Denmark.

  • The case for a second Brexit referendum: “We need the informed consent of the people” The case for a second Brexit referendum: “We need the informed consent of the people”

    As many in the pharma industry know, the EEA allows Norway, Iceland and Liechtenstein to be part of the EMA and gain access to the new medicines at the same time.

  • The tipping point The tipping point

    National policy mandates to switch from the originator to biosimilars, as has been the case in Norway, have resulted in rapid and almost complete biosimilar market penetration.

  • Building a bright future Building a bright future

    We have many examples where small molecule and biosimilars have improved uptake such as the case of infliximab in Norway, which was supported by the government that sponsored clinical trials showing

More from intelligence
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest appointments

  • Gilead Sciences appoints general manager, Canada Gilead Sciences appoints general manager, Canada

    Brysting was most recently general manager of Gilead Nordics, comprising the company's businesses in Sweden, Norway, Denmark, Finland and Iceland.

  • Targovax appoints chief financial officer Targovax appoints chief financial officer

    Dr Wiklund joins the Oslo, Norway-based immuno-oncology specialist from Aker Biomarine Antarctic, where he served as director of product innovation.

  • Algeta execs join Targovax Algeta execs join Targovax

    Anna-Kirsti Aksnes and Tina Madsen join the firm. Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.

  • Anker Lundemose appointed CEO of Bionor Pharma Anker Lundemose appointed CEO of Bionor Pharma

    The Norway-based biotech, which is focused on peptide-based vaccines for HIV, said Dr Lundemose will take over the role from March 1, when his predecessor Steen Krøyer becomes deputy

  • Matt Regan named AbbVie’s general manager in UK Matt Regan named AbbVie’s general manager in UK

    Was formerly general manager of Abbott in Norway. AbbVie, the new independent biopharma spin-out from Abbott, has appointed Matt Regan as general manager of its UK business. ... Regan was formerly general manager for Abbott in Norway and will now oversee

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics